Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma

NCT06016920

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
Locations
  • CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM) Montpellier, France
  • University of Bergen, Haukeland University Hospital Bergen, Norway
  • Oslo Universitetssykehus Oslo, Norway
  • Uniwersyteckie Cetrum Kliniczne Gdansk, Poland
View Trial Details
Recruiting

Seizure Treatment in Glioma

NCT03048084

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Amsterdam UMC Amsterdam, Netherlands
  • Medisch Spectrum Twente Enschede, Netherlands
  • Leiden University Medical Center Leiden, Netherlands
  • Erasmus Medical Center Rotterdam, Netherlands
View Trial Details
Recruiting

Digoxin Medulloblastoma Study

NCT06701812

Conditions
Glioma, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH, +8 more
Locations
  • University of Alabama at Birmingham Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

NCT06902545

Conditions
Adenocarcinoma, Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, +6 more
Locations
  • KR82010 Goyang-si, Gyeonggi-do, South Korea
  • KR82008 Suwon, Gyeonggi-do, South Korea
  • KR82009 Suwon, Gyeonggi-do, South Korea
  • KR82006 Yangsan, Gyeongsangnam-do, South Korea
View all 14 locations
View Trial Details
Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

NCT06465316

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
  • Smilow Cancer Hospital Care Center - Guilford Guilford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

NCT06833073

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0138) Bakersfield, California, United States
  • Genesis Research, LLC ( Site 0141) Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center ( Site 0123) Los Angeles, California, United States
  • Genesis Healthcare-Torrance ( Site 0140) Torrance, California, United States
View all 89 locations
View Trial Details
Recruiting

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

NCT06834282

Conditions
AML, Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Sarah Cannon Research Insitute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions